Innate Pharma SA Noncurrent Recognised Liabilities Defined Benefit Plan
Innate Pharma SA (IPHA) had Noncurrent Recognised Liabilities Defined Benefit Plan of EUR 3.76 million as of 2019-12-31, per its 20-F filed 2020-04-24.
Discontinued › Notes
ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan · last filed 2020-04-24
- 2019-12-31: Noncurrent Recognised Liabilities Defined Benefit Plan 3.76M EUR.
- 2018-12-31: Noncurrent Recognised Liabilities Defined Benefit Plan 3.70M EUR.
- 2017-12-31: Noncurrent Recognised Liabilities Defined Benefit Plan 2.62M EUR.
| Period end | Noncurrent Recognised Liabilities Defined Benefit Plan |
|---|---|
| 2019-12-31 | 3.76M EUR 20-F · filed 2020-04-24 |
| 2018-12-31 | 3.70M EUR 20-F · filed 2020-04-24 |
| 2017-12-31 | 2.62M EUR 20-F · filed 2020-04-24 |